SEC 13F Intelligence

Consonance Capital Management LP / ANIP

Consonance Capital Management LP’s Ani Pharmaceuticals Inc Position

Does Consonance Capital Management LP own Ani Pharmaceuticals Inc (ANIP)? Not currently — the last reported position was 142.9K shares worth $10M in Q3 2019; the fund’s latest 13F (Q3 2022) no longer reports it.

Position Value
$10M
Q3 2019
Shares
142.9K
% of Portfolio
+1.03%
Quarters Held
3
position exited

Position History ANIP

Reported value by quarter
Q1 ’19: $10MQ1 ’19Q2 ’19: $12MQ2 ’19Q3 ’19: $10MQ3 ’19filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2019142.9K$10M+1.03%
Q2 2019142.9K$12M+0.83%
Q1 2019142.9K$10M+0.64%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Consonance Capital Management LP’s full portfolio or all institutional holders of ANIP.